Vulnerability Details : CVE-2022-34306
IBM CICS TX Standard and Advanced 11.1 is vulnerable to HTTP header injection, caused by improper validation of input by the HOST headers. This could allow an attacker to conduct various attacks against the vulnerable system, including cross-site scripting, cache poisoning or session hijacking. IBM X-Force ID: 229435.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2022-34306
- cpe:2.3:a:ibm:cics_tx:11.1:*:*:*:advanced:*:*:*
- cpe:2.3:a:ibm:cics_tx:11.1:*:*:*:standard:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2022-34306
0.11%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 27 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2022-34306
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
5.5
|
MEDIUM | AV:N/AC:L/Au:S/C:P/I:P/A:N |
8.0
|
4.9
|
NIST | |
5.4
|
MEDIUM | CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N |
2.8
|
2.5
|
IBM Corporation | |
5.4
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N |
2.8
|
2.5
|
NIST |
CWE ids for CVE-2022-34306
-
The product constructs all or part of a command, data structure, or record using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify how it is parsed or interpreted when it is sent to a downstream component.Assigned by: nvd@nist.gov (Primary)
References for CVE-2022-34306
-
https://www.ibm.com/support/pages/node/6601659
Security Bulletin: IBM CICS TX Standard is vulnerable to HTTP Header injection (CVE-2022-34306)Patch;Vendor Advisory
-
https://exchange.xforce.ibmcloud.com/vulnerabilities/229435
IBM CICS TX HTML injection CVE-2022-34306 Vulnerability ReportVDB Entry;Vendor Advisory
-
https://www.ibm.com/support/pages/node/6601663
Security Bulletin: IBM CICS TX Advanced is vulnerable to HTTP header injection (CVE-2022-34306)Patch;Vendor Advisory
Jump to